A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
On September 26th, 2018, Hovione New Jersey held the Opening Ceremony of the site expansion. This expansion is the result of an investment over €30 million in its R&D Center.
The Mayor of East Windsor, New Jersey, Janice S. Mironov, the Hovione CEO, Guy Villax and the AICEP Commissioner in the USA, Manuel Couto Miranda were present. The new R&D center represents an expansion of the range of Hovione's service offering in the US market and includes state-of-the-art technologies in the particle engineering and continuous manufacturing areas.